Fluticasone furoate versus fluticasone propionate for seasonal allergic rhinitis: a review of the clinical and cost-effectiveness
Canadian Agency for Drugs and Technologies in Health
     
Record Status

This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.

Bibliographic details
Canadian Agency for Drugs and Technologies in Health. Fluticasone furoate versus fluticasone propionate for seasonal allergic rhinitis: a review of the clinical and cost-effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). 2011
Authors' conclusions

Two randomized controlled studies showed similar efficacy between fluticasone propionate and fluticasone furoate in the management of symptoms of seasonal allergic rhinitis; no evidence on the cost-effectiveness of fluticasone furoate as compared with fluticasone propionate was identified.

Original Paper URL
http://www.cadth.ca/media/pdf/htis/june-2011/RC0284_ Fluticasone_ Fuorate_ Final.pdf
Indexing Status
Subject indexing assigned by CRD
MeSH
Anti-Allergic Agents /administration & dosage /therapeutic use; Cost-Benefit Analysis; Humans; Rhinitis, Allergic, Seasonal /drug therapy
Language Published
English
Address for correspondence
Canadian Agency for Drugs and Technologies in Health, 865 Carling Avenue, Suite 600, K1S 5S8 Ottawa, Ontario Canada Email: htainfo@cadth.ca
AccessionNumber
32011001021
Database entry date
27/07/2011
     
Health Technology Assessment (HTA) database
Copyright © 2012 Canadian Agency for Drugs and Technologies in Health (CADTH)
 
Options
Print
PDF
 
Set alert
Fast track
PubMed record
Original research
 
Share
|
 
You need to be logged in to see your keywords

Assign your own keywords to this record. You can search on your keywords in Advanced Search.

(Hold the CTRL key to assign multiple keywords from the list.)

 

Create a new keyword